Anderson Donald G
University of Newcastle, Department of Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle, NSW, Australia.
Pediatr Diabetes. 2009 Aug;10(5):304-9. doi: 10.1111/j.1399-5448.2008.00484.x. Epub 2008 Dec 5.
To describe the easy bolus insulin calculation card (ezy-BICC) approach to multiple daily injections and to compare in an observational study, the haemoglobin A1c (HbA1c) achieved while using ezy-BICC, mixed insulin injections and continuous subcutaneous insulin infusion (CSII).
HbA1c results from 7121 clinic visits by 573 patients aged 1-20 yr using the three methods between June 2000 and July 2008 were reviewed.
For mixed insulin median, mean and SD HbA1c were 8.3%, 8.3%, 1.33, for ezy-BICC, 7.6%, 7.7%, 1.40, and for CSII, 7.6%, 7.8%, 1.31. HbA1c increases with age significantly more in those using CSII (p < 0.001). By regression, compared with mixed insulin HbA1c is 0.7% lower using ezy-BICC (p < 0.018) and 1.5% lower using CSII (p < 0.001). For patients using CSII compared with <6 yr, those 6-12 yr have HbA1c 0.7% higher (p < 0.001), 12-15 yr 1.0% higher (p < 0.001) and 15-20 yr 1.2% higher (p < 0.001). For subjects >12 yr, HbA1c is lower while using ezy-BICC than CSII. HbA1c increases 0.2% per yr following diagnosis for 2.8 yr. In those who change from mixed insulin to ezy-BICC after this time, the mean HbA1c is 0.5% lower by 9 months, 0.7% lower at 21 months and 0.6% lower at 24 months (p < 0.05).
The ezy-BICC system is inexpensive and convenient and allows patients to vary meal size. Subjects achieve lower HbA1c while using CSII and ezy-BICC MDI than with mixed insulin. Very young subjects achieve excellent HbA1c using CSII, but for 12 to 20 yr-old patients, ezy-BICC results in lower HbA1c than CSII for a lower cost.
描述用于多次皮下注射的简易大剂量胰岛素计算卡(ezy-BICC)方法,并在一项观察性研究中比较使用ezy-BICC、混合胰岛素注射和持续皮下胰岛素输注(CSII)时所达到的糖化血红蛋白(HbA1c)水平。
回顾了2000年6月至2008年7月间573例1至20岁患者使用这三种方法进行的7121次门诊就诊的HbA1c结果。
混合胰岛素组的HbA1c中位数、均值和标准差分别为8.3%、8.3%、1.33;ezy-BICC组分别为7.6%、7.7%、1.40;CSII组分别为7.6%、7.8%、1.31。使用CSII的患者中,HbA1c随年龄增长的幅度显著更大(p<0.001)。通过回归分析,与混合胰岛素相比,使用ezy-BICC时HbA1c低0.7%(p<0.018),使用CSII时低1.5%(p<0.001)。与<6岁使用CSII的患者相比,6-12岁患者的HbA1c高0.7%(p<0.001),12-15岁患者高1.0%(p<0.001),15-20岁患者高1.2%(p<0.001)。对于>12岁的受试者,使用ezy-BICC时的HbA1c低于CSII。确诊后2.8年期间,HbA1c每年增加0.2%。在此之后从混合胰岛素转换为ezy-BICC的患者,9个月时平均HbA1c低0.5%,21个月时低0.7%,24个月时低0.6%(p<0.05)。
ezy-BICC系统价格低廉且方便,允许患者调整饮食量。与混合胰岛素相比,使用CSII和ezy-BICC多次皮下注射时受试者的HbA1c更低。非常年幼的受试者使用CSII可达到优异的HbA1c水平,但对于12至20岁的患者,ezy-BICC以更低的成本使HbA1c低于CSII。